Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Coferon Inc.

Latest From Coferon Inc.

G1 Therapeutics Gets $12.5M Series A To Advance Chemo-Protectant Agent

Based on research from the University of North Carolina and seeded by Hatteras Venture Partners, the start-up is developing cyclin-dependent kinase (CDK) 4/6 inhibitors for use in protecting the bone marrow of cancer patients receiving chemotherapy. The funding should bring the biotech through IND filing and into Phase I work.

BioPharmaceutical United States

Start-Up Execs On The Move, September 2012

Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.

Medical Device BioPharmaceutical

Recent Financings Of Private Companies, September 2012

START-UP's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical equipment & supplies.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Site Specific
  • Therapeutic Areas
  • Cancer
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Coferon Inc.
  • Senior Management
  • Colin Goddard, PhD, Chmn. & CEO
    Lee Arnold, PhD, CSO
  • Contact Info
  • Coferon Inc.
    Phone: (631) 697-0276
    551 Fifth Ave., 34th Fl.
    New York, NY 10176